News
20.05.2024
Bridge Capture™ by Genomill represents a major leap forward in liquid biopsy diagnostics
The new method will enable cost-efficient, rapid, and sensitive molecular precision diagnostics for cancer.
13.06.2023
Genomill and Finland’s Cancer Research Flagship iCAN Partner To Improve Cancer Detection Using an Extensive Biobank Cohort
Genomill, a pioneering precision diagnostics company, brings its cutting-edge Geno1® platform to the […]
27.06.2022
Genomill appoints former Foundation Medicine executive and plans to present unmatched data at PMWC
Genomill, a precision diagnostics company focused on maximizing next generation sequencing (NGS) in […]